BIO-RAD LABORATORIES INC
For the period ended Jun 30, 2024. Filed Aug 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 2, 2024
BIO-B$389.98+2.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Income (Loss)
(In thousands, except per share data)
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| June 30, | June 30, | |||
| 2024 | 2023 | 2024 | 2023 | |
| Net sales | $638,476 | $681,110 | $1,249,296 | $1,357,954 |
| Cost of goods sold | 283,357 | 318,627 | 568,211 | 633,054 |
| Gross profit | 355,119 | 362,483 | 681,085 | 724,900 |
| Selling, general and administrative expense | 194,719 | 207,824 | 409,602 | 433,377 |
| Research and development expense | 58,904 | 65,042 | 125,279 | 139,993 |
| Income from operations | 101,496 | 89,617 | 146,204 | 151,530 |
| Interest expense | 12,264 | 12,343 | 24,541 | 24,680 |
| Foreign currency exchange gains, net | (1,699) | (1,253) | (3,653) | (3,600) |
| Losses from change in fair market value of equity securities and loan receivable | 2,895,355 | 1,595,442 | 2,473,178 | 1,612,967 |
| Other income, net | (18,143) | (16,488) | (52,659) | (66,919) |
| Loss before income taxes | (2,786,281) | (1,500,427) | (2,295,203) | (1,415,598) |
| Benefit from income taxes | 620,795 | 338,176 | 513,633 | 322,309 |
| Net loss | $(2,165,486) | $(1,162,251) | $(1,781,570) | $(1,093,289) |
| Basic and diluted loss per share: | ||||
| Net loss per share | $(76.26) | $(39.59) | $(62.61) | $(37.09) |
| Weighted average common shares | 28,395 | 29,355 | 28,457 | 29,475 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.